drugset / Trial / NCT06314256
Clinical Evaluation of Hyaluronic Acid and Platelet Rich Fibrin Injection Efficacy in Interdental Papilla Reconstruction
RandomizedCrossoverDouble-blindTreatment
Summary
The goal of this clinical trial is to evaluate and compare the efficacy of injectable platelet rich fibrin (i-PRF) and hyaluronic acid (HA) in reconstruction of interdental papilla loss. The main questions it aims to answer are: * How compareable are above mentioned two interventions (i-PRF\&HA) in reconstruction of interdental papilla loss? * Which treatment option is better accepted by patients? Which treatment option would patients be more satisfied with? Participants with multiple interdental papilla loss will be treated with both i-PRF and HA in split-mouth design. Researchers will compare two treatment options to see if black triangles caused by interdental papilla loss closes and if yes, for how long do they last.
Timeline
- Start
- 2024-04-10
- Primary completion
- 2025-06-01
- Completion
- 2025-06-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hyaluronic Acid | Other / unclassified | 0.1 ml | Other |
| Comparator | Hyaluronic Acid | Other / unclassified | 0.2 ml | Other |
| Comparator | i-PRF | Other / unclassified | 0.1 ml | Other |
| Comparator | i-PRF | Other / unclassified | 0.2 ml | Other |